Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04525131
Title Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors CicloMed LLC
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.